- Forums
- ASX - By Stock
- MSB
- Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS
Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS, page-2
-
- There are more pages in this discussion • 571 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
FWD
Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.20 |
Change
0.090(8.14%) |
Mkt cap ! $1.358B |
Open | High | Low | Value | Volume |
$1.10 | $1.20 | $1.09 | $9.988M | 8.658M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
39 | 104843 | $1.19 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.20 | 88945 | 18 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
34 | 95584 | 1.190 |
16 | 77973 | 1.185 |
19 | 142598 | 1.180 |
11 | 134280 | 1.175 |
7 | 132798 | 1.170 |
Price($) | Vol. | No. |
---|---|---|
1.195 | 86467 | 15 |
1.200 | 738877 | 54 |
1.205 | 97281 | 11 |
1.210 | 249831 | 16 |
1.215 | 129338 | 6 |
Last trade - 14.34pm 12/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |